N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide

C24H32F3N7O2 — CID 126537367

IUPACN-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide
SMILESCCCCC(Cc1c[nH]c2ccccc12)NC(=O)c1nc(N2CCN(CCOC(F)(F)F)CC2)n[nH]1
InChIInChI=1S/C24H32F3N7O2/c1-2-3-6-18(15-17-16-28-20-8-5-4-7-19(17)20)29-22(35)21-30-23(32-31-21)34-11-9-33(10-12-34)13-14-36-24(25,26)27/h4-5,7-8,16,18,28H,2-3,6,9-15H2,1H3,(H,29,35)(H,30,31,32)
InChIKeyCUDXNTWOVRVWRV-UHFFFAOYSA-N
MW507.56 g/mol
LogP3.48
Rot. Bonds11

About N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide

N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide (PubChem CID 126537367) has the molecular formula C24H32F3N7O2 and a molecular weight of 507.56 g/mol. Its IUPAC name is N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide.

Molecular Properties

Compound NameN-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide
PubChem CID126537367
Molecular FormulaC24H32F3N7O2
Molecular Weight507.56 g/mol
Exact Mass507.26
IUPAC NameN-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide
SMILESCCCCC(Cc1c[nH]c2ccccc12)NC(=O)c1nc(N2CCN(CCOC(F)(F)F)CC2)n[nH]1
InChIInChI=1S/C24H32F3N7O2/c1-2-3-6-18(15-17-16-28-20-8-5-4-7-19(17)20)29-22(35)21-30-23(32-31-21)34-11-9-33(10-12-34)13-14-36-24(25,26)27/h4-5,7-8,16,18,28H,2-3,6,9-15H2,1H3,(H,29,35)(H,30,31,32)
InChIKeyCUDXNTWOVRVWRV-UHFFFAOYSA-N
XLogP3.48
TPSA102.17 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds11
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500507.56
LogP ≤ 53.48
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide?
The IUPAC name of N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide (CID 126537367) is N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide.
What is the SMILES notation for N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide?
The canonical SMILES for N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide is CCCCC(Cc1c[nH]c2ccccc12)NC(=O)c1nc(N2CCN(CCOC(F)(F)F)CC2)n[nH]1.
What is the InChIKey of N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide?
The InChIKey is CUDXNTWOVRVWRV-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H32F3N7O2/c1-2-3-6-18(15-17-16-28-20-8-5-4-7-19(17)20)29-22(35)21-30-23(32-31-21)34-11-9-33(10-12-34)13-14-36-24(25,26)27/h4-5,7-8,16,18,28H,2-3,6,9-15H2,1H3,(H,29,35)(H,30,31,32).
What are the key properties of N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide?
N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide has a molecular weight of 507.56 g/mol, XLogP of 3.48, 11 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(1H-indol-3-yl)hexan-2-yl]-3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazole-5-carboxamide is sourced from PubChem (CID 126537367), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).